Athersys, Inc.

ATHX | NASDAQ | 0 Followers
$0.01 -33.50% $0.0068
Follow
Loading...

Profile

Athersys, Inc. (ATHX) is a biotechnology company focused on the development of regenerative therapeutic treatments and biological products. The company is dedicated to researching and developing therapeutic approaches aimed at tissue and cell regeneration. Athersys is engaged in innovative treatment methodologies, including the treatment of cardiovascular diseases, inflammation, brain injuries, and other health conditions. Their technology involves the use of intestinal cells and other cell types for therapeutic purposes. Shares of Athersys, Inc. (ATHX) can be an interesting choice for investors tracking innovations in the field of regenerative medicine and biotechnologies.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade